Grapefruit USA, Inc. Announces NNCP Submission to Health Canada to Enable Canada-Wide Sale of Grapefruit’s Patented Hourglass™ Time Release THC+CBD Delivery Cream
20 janv. 2022 06h00 HE
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Jan. 20, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
Grapefruit USA, Inc. Outlines 2022 Corporate Evolution
18 janv. 2022 06h00 HE
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Jan. 18, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), an innovative California-based...
Optimi Health Provides Dealer License Update and Comments on Health Canada’s Amendments to the Special Access Program (SAP)
05 janv. 2022 16h17 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Receives Dealers License Inspection and Introduces Quality Assurance Department
21 déc. 2021 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
Optimi Health Engages Expert Management Consultancy to Drive Corporate Visibility
03 nov. 2021 09h00 HE
|
Optimi Health Corp.
VANCOUVER, British Columbia, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Optimi Health Corp. (CSE: OPTI) (OTCQB: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), developers of a vertically integrated mushroom...
The Cannabis Community’s “Not Done Yet Report Card” Gives Legalization a “D”
18 oct. 2021 10h56 HE
|
Cannabis Council of Canada
Ottawa, ON, Oct. 18, 2021 (GLOBE NEWSWIRE) -- In support of the historic third anniversary of the legalization of adult-use cannabis, the Cannabis Council of Canada (C3), the national organization...
Grapefruit USA, Inc. Announces Expanded Agreement with Canadian Firms Medz Cannabis and 6PAK Solutions to Shepherd Grapefruit’s Patented Hourglass™ Time Release THC+CBD Delivery Cream Through Health Canada’s Regulatory Process
13 oct. 2021 06h00 HE
|
Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere California-based...
Helsinn Group and BridgeBio Pharma’s Affiliate QED Therapeutics Announce Health Canada Conditional Approval of TRUSELTIQ™ (infigratinib) for Patients with Cholangiocarcinoma
29 sept. 2021 07h30 HE
|
Helsinn Healthcare S.A.
Helsinn Group and BridgeBio Pharma’s Affiliate QED Therapeutics Announce Health Canada Conditional Approval of TRUSELTIQ™ (infigratinib) for Patients with Cholangiocarcinoma - Health Canada Issues...
New poll shows a strong base of Canadians overwhelmingly support controlled legal access to psilocybin-assisted therapy; Canadian Psychedelic Association responds with Memorandum of Regulatory Approval (MORA)
04 août 2021 07h02 HE
|
Canadian Psychedelic Association
Vancouver, BC, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A Nanos Research Survey released today by the Canadian Psychedelic Association (CPA) shows 82 percent of Canadians approve the use of...
Pure Extracts Submits Natural Health Product Licence Application for Blended Functional Mushroom Product
13 juil. 2021 08h50 HE
|
Pure Extracts Technologies Corp.
VANCOUVER, British Columbia, July 13, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction...